UniProt ID | CNDD3_HUMAN | |
---|---|---|
UniProt AC | P42695 | |
Protein Name | Condensin-2 complex subunit D3 | |
Gene Name | NCAPD3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1498 | |
Subcellular Localization | Nucleus . | |
Protein Description | Regulatory subunit of the condensin-2 complex, a complex which establishes mitotic chromosome architecture and is involved in physical rigidity of the chromatid axis.. | |
Protein Sequence | MVALRGLGSGLQPWCPLDLRLEWVDTVWELDFTETEPLDPSIEAEIIETGLAAFTKLYESLLPFATGEHGSMESIWTFFIENNVSHSTLVALFYHFVQIVHKKNVSVQYREYGLHAAGLYFLLLEVPGSVANQVFHPVMFDKCIQTLKKSWPQESNLNRKRKKEQPKSSQANPGRHRKRGKPPRREDIEMDEIIEEQEDENICFSARDLSQIRNAIFHLLKNFLRLLPKFSLKEKPQCVQNCIEVFVSLTNFEPVLHECHVTQARALNQAKYIPELAYYGLYLLCSPIHGEGDKVISCVFHQMLSVILMLEVGEGSHRAPLAVTSQVINCRNQAVQFISALVDELKESIFPVVRILLQHICAKVVDKSEYRTFAAQSLVQLLSKLPCGEYAMFIAWLYKYSRSSKIPHRVFTLDVVLALLELPEREVDNTLSLEHQKFLKHKFLVQEIMFDRCLDKAPTVRSKALSSFAHCLELTVTSASESILELLINSPTFSVIESHPGTLLRNSSAFSYQRQTSNRSEPSGEINIDSSGETVGSGERCVMAMLRRRIRDEKTNVRKSALQVLVSILKHCDVSGMKEDLWILQDQCRDPAVSVRKQALQSLTELLMAQPRCVQIQKAWLRGVVPVVMDCESTVQEKALEFLDQLLLQNIRHHSHFHSGDDSQVLAWALLTLLTTESQELSRYLNKAFHIWSKKEKFSPTFINNVISHTGTEHSAPAWMLLSKIAGSSPRLDYSRIIQSWEKISSQQNPNSNTLGHILCVIGHIAKHLPKSTRDKVTDAVKCKLNGFQWSLEVISSAVDALQRLCRASAETPAEEQELLTQVCGDVLSTCEHRLSNIVLKENGTGNMDEDLLVKYIFTLGDIAQLCPARVEKRIFLLIQSVLASSADADHSPSSQGSSEAPASQPPPQVRGSVMPSVIRAHAIITLGKLCLQHEDLAKKSIPALVRELEVCEDVAVRNNVIIVMCDLCIRYTIMVDKYIPNISMCLKDSDPFIRKQTLILLTNLLQEEFVKWKGSLFFRFVSTLIDSHPDIASFGEFCLAHLLLKRNPVMFFQHFIECIFHFNNYEKHEKYNKFPQSEREKRLFSLKGKSNKERRMKIYKFLLEHFTDEQRFNITSKICLSILACFADGILPLDLDASELLSDTFEVLSSKEIKLLAMRSKPDKDLLMEEDDMALANVVMQEAQKKLISQVQKRNFIENIIPIIISLKTVLEKNKIPALRELMHYLREVMQDYRDELKDFFAVDKQLASELEYDMKKYQEQLVQEQELAKHADVAGTAGGAEVAPVAQVALCLETVPVPAGQENPAMSPAVSQPCTPRASAGHVAVSSPTPETGPLQRLLPKARPMSLSTIAILNSVKKAVESKSRHRSRSLGVLPFTLNSGSPEKTCSQVSSYSLEQESNGEIEHVTKRAISTPEKSISDVTFGAGVSYIGTPRTPSSAKEKIEGRSQGNDILCLSLPDKPPPQPQQWNVRSPARNKDTPACSRRSLRKTPLKTAN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | VALRGLGSGLQPWCP CCCCCCCCCCCCCCC | 41.18 | 28122231 | |
11 | Ubiquitination | LRGLGSGLQPWCPLD CCCCCCCCCCCCCCC | 6.23 | 22505724 | |
106 | Phosphorylation | IVHKKNVSVQYREYG HHHHCCCCHHHHHHC | 16.94 | 20860994 | |
109 | Phosphorylation | KKNVSVQYREYGLHA HCCCCHHHHHHCCHH | 11.85 | 20860994 | |
148 | Ubiquitination | DKCIQTLKKSWPQES HHHHHHHHHHCCCHH | 48.42 | - | |
149 | Ubiquitination | KCIQTLKKSWPQESN HHHHHHHHHCCCHHH | 61.95 | 22505724 | |
167 | Ubiquitination | KRKKEQPKSSQANPG HHHHCCCCCCCCCCC | 63.53 | 29967540 | |
229 | Ubiquitination | NFLRLLPKFSLKEKP HHHHHHHHCCCCCCH | 47.78 | 29967540 | |
324 | Phosphorylation | HRAPLAVTSQVINCR CCCCCEEHHHHHCCH | 14.08 | 28555341 | |
325 | Phosphorylation | RAPLAVTSQVINCRN CCCCEEHHHHHCCHH | 18.82 | 20860994 | |
372 | Phosphorylation | VDKSEYRTFAAQSLV CCHHHHHHHHHHHHH | 19.41 | 24114839 | |
377 | Phosphorylation | YRTFAAQSLVQLLSK HHHHHHHHHHHHHHC | 26.27 | 24114839 | |
383 | Phosphorylation | QSLVQLLSKLPCGEY HHHHHHHHCCCCHHH | 40.51 | 24719451 | |
400 | Phosphorylation | FIAWLYKYSRSSKIP HHHHHHHHHCCCCCC | 8.85 | 29116813 | |
412 | Phosphorylation | KIPHRVFTLDVVLAL CCCCCCHHHHHHHHH | 21.13 | - | |
430 | Phosphorylation | PEREVDNTLSLEHQK CHHHCCCCCCHHHHH | 17.17 | 19691289 | |
432 | Phosphorylation | REVDNTLSLEHQKFL HHCCCCCCHHHHHHH | 29.67 | 19691289 | |
442 | Ubiquitination | HQKFLKHKFLVQEIM HHHHHHHHHHHHHHH | 38.51 | 29967540 | |
456 | Acetylation | MFDRCLDKAPTVRSK HHHHHHHCCCCHHHH | 43.23 | 26051181 | |
456 | Ubiquitination | MFDRCLDKAPTVRSK HHHHHHHCCCCHHHH | 43.23 | 29967540 | |
480 | Ubiquitination | ELTVTSASESILELL HCCCCCCCHHHHHHH | 31.48 | 22505724 | |
490 | Phosphorylation | ILELLINSPTFSVIE HHHHHHCCCCEEEHH | 20.51 | 26074081 | |
492 | Phosphorylation | ELLINSPTFSVIESH HHHHCCCCEEEHHCC | 28.50 | 26074081 | |
507 | Phosphorylation | PGTLLRNSSAFSYQR CCCEECCCCCCCCCC | 19.33 | 19691289 | |
508 | Phosphorylation | GTLLRNSSAFSYQRQ CCEECCCCCCCCCCC | 36.56 | 25159151 | |
511 | Phosphorylation | LRNSSAFSYQRQTSN ECCCCCCCCCCCCCC | 21.77 | 26055452 | |
512 | Phosphorylation | RNSSAFSYQRQTSNR CCCCCCCCCCCCCCC | 10.97 | 18083107 | |
516 | Phosphorylation | AFSYQRQTSNRSEPS CCCCCCCCCCCCCCC | 30.11 | 28102081 | |
517 | Phosphorylation | FSYQRQTSNRSEPSG CCCCCCCCCCCCCCC | 23.16 | 25159151 | |
520 | Phosphorylation | QRQTSNRSEPSGEIN CCCCCCCCCCCCEEE | 59.10 | 25159151 | |
523 | Phosphorylation | TSNRSEPSGEINIDS CCCCCCCCCEEEECC | 45.03 | 25159151 | |
530 | Phosphorylation | SGEINIDSSGETVGS CCEEEECCCCCCCCC | 36.12 | 23401153 | |
531 | Phosphorylation | GEINIDSSGETVGSG CEEEECCCCCCCCCH | 36.58 | 30175587 | |
534 | Phosphorylation | NIDSSGETVGSGERC EECCCCCCCCCHHHH | 33.42 | 30175587 | |
537 | Phosphorylation | SSGETVGSGERCVMA CCCCCCCCHHHHHHH | 32.90 | 29978859 | |
554 | Ubiquitination | RRRIRDEKTNVRKSA HHHHHHCCCHHHHHH | 50.08 | 29967540 | |
559 | Ubiquitination | DEKTNVRKSALQVLV HCCCHHHHHHHHHHH | 35.48 | - | |
560 | Phosphorylation | EKTNVRKSALQVLVS CCCHHHHHHHHHHHH | 24.52 | 22199227 | |
567 | Phosphorylation | SALQVLVSILKHCDV HHHHHHHHHHHCCCC | 20.31 | 20068231 | |
578 | Acetylation | HCDVSGMKEDLWILQ CCCCCCCHHCEEHHH | 52.15 | 25953088 | |
578 | Ubiquitination | HCDVSGMKEDLWILQ CCCCCCCHHCEEHHH | 52.15 | 29967540 | |
597 | Ubiquitination | DPAVSVRKQALQSLT CCHHHHHHHHHHHHH | 37.45 | 29967540 | |
604 | Phosphorylation | KQALQSLTELLMAQP HHHHHHHHHHHHCCC | 29.81 | 24043423 | |
618 | Ubiquitination | PRCVQIQKAWLRGVV CCHHHHHHHHHCCCC | 43.06 | 22505724 | |
687 | Ubiquitination | ELSRYLNKAFHIWSK HHHHHHHHHHHHHCC | 50.24 | - | |
697 | Ubiquitination | HIWSKKEKFSPTFIN HHHCCCCCCCHHHHH | 61.08 | 29967540 | |
699 | Phosphorylation | WSKKEKFSPTFINNV HCCCCCCCHHHHHCC | 33.81 | 27174698 | |
701 | Phosphorylation | KKEKFSPTFINNVIS CCCCCCHHHHHCCCC | 35.63 | 27174698 | |
708 | Phosphorylation | TFINNVISHTGTEHS HHHHCCCCCCCCCCC | 15.66 | 27174698 | |
710 | Phosphorylation | INNVISHTGTEHSAP HHCCCCCCCCCCCCC | 38.72 | 27174698 | |
712 | Phosphorylation | NVISHTGTEHSAPAW CCCCCCCCCCCCCHH | 31.51 | 27174698 | |
715 | Phosphorylation | SHTGTEHSAPAWMLL CCCCCCCCCCHHHHH | 29.70 | 27174698 | |
724 | Ubiquitination | PAWMLLSKIAGSSPR CHHHHHHHHHCCCCC | 36.22 | - | |
728 | Phosphorylation | LLSKIAGSSPRLDYS HHHHHHCCCCCCCHH | 28.31 | 26699800 | |
729 | Phosphorylation | LSKIAGSSPRLDYSR HHHHHCCCCCCCHHH | 17.08 | 26699800 | |
743 | Ubiquitination | RIIQSWEKISSQQNP HHHHHHHHHHCCCCC | 41.45 | - | |
771 | Ubiquitination | HIAKHLPKSTRDKVT HHHHHCCCCCCCHHH | 71.47 | 29967540 | |
776 | Ubiquitination | LPKSTRDKVTDAVKC CCCCCCCHHHHHHHH | 43.68 | 29967540 | |
782 | Ubiquitination | DKVTDAVKCKLNGFQ CHHHHHHHHHCCCCH | 27.63 | 29967540 | |
841 | Ubiquitination | RLSNIVLKENGTGNM HHHCCEEEECCCCCC | 37.93 | - | |
881 | Phosphorylation | RIFLLIQSVLASSAD HHHHHHHHHHHHCCC | 16.47 | 28122231 | |
885 | Phosphorylation | LIQSVLASSADADHS HHHHHHHHCCCCCCC | 23.15 | 28348404 | |
886 | Phosphorylation | IQSVLASSADADHSP HHHHHHHCCCCCCCC | 25.26 | 28348404 | |
892 | Phosphorylation | SSADADHSPSSQGSS HCCCCCCCCCCCCCC | 27.33 | 28348404 | |
894 | Phosphorylation | ADADHSPSSQGSSEA CCCCCCCCCCCCCCC | 38.00 | 22817901 | |
895 | Phosphorylation | DADHSPSSQGSSEAP CCCCCCCCCCCCCCC | 41.78 | 18077418 | |
898 | Phosphorylation | HSPSSQGSSEAPASQ CCCCCCCCCCCCCCC | 19.85 | 28348404 | |
899 | Phosphorylation | SPSSQGSSEAPASQP CCCCCCCCCCCCCCC | 44.60 | 28348404 | |
929 | Ubiquitination | HAIITLGKLCLQHED HHHHHHHHHHHCCHH | 38.86 | - | |
939 | Acetylation | LQHEDLAKKSIPALV HCCHHHHHCCHHHHH | 55.11 | 26051181 | |
939 | Ubiquitination | LQHEDLAKKSIPALV HCCHHHHHCCHHHHH | 55.11 | 29967540 | |
940 | Ubiquitination | QHEDLAKKSIPALVR CCHHHHHCCHHHHHH | 48.27 | - | |
972 | Phosphorylation | MCDLCIRYTIMVDKY ECCHHHHHHHHHCCC | 4.82 | 17924679 | |
973 | Phosphorylation | CDLCIRYTIMVDKYI CCHHHHHHHHHCCCC | 7.86 | 22210691 | |
988 | Ubiquitination | PNISMCLKDSDPFIR CCHHHHCCCCCHHHH | 50.70 | 29967540 | |
1074 | Ubiquitination | EKHEKYNKFPQSERE HHHHHHCCCCHHHHH | 56.16 | 29967540 | |
1086 | Phosphorylation | EREKRLFSLKGKSNK HHHHHHHHCCCCCCH | 33.49 | 24719451 | |
1088 | Ubiquitination | EKRLFSLKGKSNKER HHHHHHCCCCCCHHH | 64.19 | - | |
1101 | Acetylation | ERRMKIYKFLLEHFT HHHHHHHHHHHHHCC | 32.77 | 26051181 | |
1108 | Ubiquitination | KFLLEHFTDEQRFNI HHHHHHCCHHHHCCC | 40.30 | 22817900 | |
1119 | Ubiquitination | RFNITSKICLSILAC HCCCCHHHHHHHHHH | 2.60 | 22817900 | |
1120 | Ubiquitination | FNITSKICLSILACF CCCCHHHHHHHHHHH | 2.54 | 21890473 | |
1155 | Ubiquitination | VLSSKEIKLLAMRSK HHCHHHHHHHHHCCC | 38.24 | 29967540 | |
1162 | Ubiquitination | KLLAMRSKPDKDLLM HHHHHCCCCCHHHCC | 47.04 | - | |
1165 | Ubiquitination | AMRSKPDKDLLMEED HHCCCCCHHHCCCHH | 59.82 | - | |
1175 | Phosphorylation | LMEEDDMALANVVMQ CCCHHHHHHHHHHHH | 15.54 | 32645325 | |
1187 | Ubiquitination | VMQEAQKKLISQVQK HHHHHHHHHHHHHHH | 38.68 | 29967540 | |
1193 | Phosphorylation | KKLISQVQKRNFIEN HHHHHHHHHHCHHHH | 31.21 | 32142685 | |
1194 | Ubiquitination | KLISQVQKRNFIENI HHHHHHHHHCHHHHH | 50.91 | 29967540 | |
1207 | Phosphorylation | NIIPIIISLKTVLEK HHHHHHHHHHHHHHH | 17.26 | 24719451 | |
1216 | Acetylation | KTVLEKNKIPALREL HHHHHHCCCHHHHHH | 62.22 | 7825993 | |
1246 | Phosphorylation | KDFFAVDKQLASELE HHHHHHCHHHHHHHH | 40.38 | 32142685 | |
1246 | Ubiquitination | KDFFAVDKQLASELE HHHHHHCHHHHHHHH | 40.38 | 21906983 | |
1250 | Phosphorylation | AVDKQLASELEYDMK HHCHHHHHHHHHHHH | 51.84 | 19691289 | |
1257 | Ubiquitination | SELEYDMKKYQEQLV HHHHHHHHHHHHHHH | 45.49 | 22817900 | |
1258 | Ubiquitination | ELEYDMKKYQEQLVQ HHHHHHHHHHHHHHH | 45.59 | 22817900 | |
1278 | Phosphorylation | KHADVAGTAGGAEVA HHCCCCCCCCCCCCC | 16.64 | 24043423 | |
1296 | Phosphorylation | QVALCLETVPVPAGQ HEEEHHCCCCCCCCC | 19.70 | 26074081 | |
1304 | Ubiquitination | VPVPAGQENPAMSPA CCCCCCCCCCCCCCC | 65.35 | 24816145 | |
1309 | Phosphorylation | GQENPAMSPAVSQPC CCCCCCCCCCCCCCC | 16.29 | 26074081 | |
1313 | Phosphorylation | PAMSPAVSQPCTPRA CCCCCCCCCCCCCCC | 30.43 | 26074081 | |
1317 | Phosphorylation | PAVSQPCTPRASAGH CCCCCCCCCCCCCCC | 23.61 | 26074081 | |
1321 | Phosphorylation | QPCTPRASAGHVAVS CCCCCCCCCCCEEEE | 35.74 | 25159151 | |
1328 | Phosphorylation | SAGHVAVSSPTPETG CCCCEEEECCCCCCC | 22.36 | 25159151 | |
1329 | Phosphorylation | AGHVAVSSPTPETGP CCCEEEECCCCCCCH | 26.62 | 25159151 | |
1331 | Phosphorylation | HVAVSSPTPETGPLQ CEEEECCCCCCCHHH | 35.39 | 25159151 | |
1334 | Phosphorylation | VSSPTPETGPLQRLL EECCCCCCCHHHHHC | 45.35 | 25159151 | |
1348 | Phosphorylation | LPKARPMSLSTIAIL CCCCCCCCHHHHHHH | 23.11 | 22167270 | |
1350 | Phosphorylation | KARPMSLSTIAILNS CCCCCCHHHHHHHHH | 15.51 | 22167270 | |
1351 | Phosphorylation | ARPMSLSTIAILNSV CCCCCHHHHHHHHHH | 21.52 | 22167270 | |
1353 | Ubiquitination | PMSLSTIAILNSVKK CCCHHHHHHHHHHHH | 10.58 | 24816145 | |
1357 | Phosphorylation | STIAILNSVKKAVES HHHHHHHHHHHHHHC | 31.69 | 22167270 | |
1360 | Ubiquitination | AILNSVKKAVESKSR HHHHHHHHHHHCCCC | 56.35 | - | |
1366 | Phosphorylation | KKAVESKSRHRSRSL HHHHHCCCCHHCCCC | 42.47 | - | |
1370 | Phosphorylation | ESKSRHRSRSLGVLP HCCCCHHCCCCCEEE | 21.79 | 22617229 | |
1372 | Phosphorylation | KSRHRSRSLGVLPFT CCCHHCCCCCEEEEE | 30.62 | 28355574 | |
1379 | Phosphorylation | SLGVLPFTLNSGSPE CCCEEEEECCCCCCC | 24.08 | 30266825 | |
1382 | Phosphorylation | VLPFTLNSGSPEKTC EEEEECCCCCCCCCH | 43.70 | 29255136 | |
1384 | Phosphorylation | PFTLNSGSPEKTCSQ EEECCCCCCCCCHHH | 29.70 | 29255136 | |
1388 | Phosphorylation | NSGSPEKTCSQVSSY CCCCCCCCHHHHCCC | 18.74 | 22210691 | |
1390 | Phosphorylation | GSPEKTCSQVSSYSL CCCCCCHHHHCCCEE | 38.56 | 22210691 | |
1393 | Phosphorylation | EKTCSQVSSYSLEQE CCCHHHHCCCEEECC | 18.87 | 16565220 | |
1410 | Ubiquitination | GEIEHVTKRAISTPE CCEEEHHHHCCCCCC | 38.45 | 29967540 | |
1414 | Phosphorylation | HVTKRAISTPEKSIS EHHHHCCCCCCCCHH | 36.60 | 30576142 | |
1415 | Phosphorylation | VTKRAISTPEKSISD HHHHCCCCCCCCHHH | 29.38 | 25159151 | |
1418 | Acetylation | RAISTPEKSISDVTF HCCCCCCCCHHHCEE | 55.05 | 26051181 | |
1419 | Phosphorylation | AISTPEKSISDVTFG CCCCCCCCHHHCEEC | 26.18 | 30624053 | |
1421 | Phosphorylation | STPEKSISDVTFGAG CCCCCCHHHCEECCC | 32.87 | 30624053 | |
1424 | Phosphorylation | EKSISDVTFGAGVSY CCCHHHCEECCCCEE | 22.72 | - | |
1434 | Phosphorylation | AGVSYIGTPRTPSSA CCCEECCCCCCCCCH | 10.47 | 21712546 | |
1437 | Phosphorylation | SYIGTPRTPSSAKEK EECCCCCCCCCHHHH | 28.82 | 21712546 | |
1439 | Phosphorylation | IGTPRTPSSAKEKIE CCCCCCCCCHHHHHC | 42.17 | 20860994 | |
1442 | Ubiquitination | PRTPSSAKEKIEGRS CCCCCCHHHHHCCCC | 62.58 | 24816145 | |
1449 | Phosphorylation | KEKIEGRSQGNDILC HHHHCCCCCCCCEEE | 53.98 | 25159151 | |
1458 | Phosphorylation | GNDILCLSLPDKPPP CCCEEEEECCCCCCC | 36.54 | 25159151 | |
1462 | Ubiquitination | LCLSLPDKPPPQPQQ EEEECCCCCCCCCCC | 58.44 | 29967540 | |
1474 | Phosphorylation | PQQWNVRSPARNKDT CCCCCCCCCCCCCCC | 20.73 | 30576142 | |
1481 | Phosphorylation | SPARNKDTPACSRRS CCCCCCCCCCCCCCH | 17.88 | 26074081 | |
1485 | Phosphorylation | NKDTPACSRRSLRKT CCCCCCCCCCHHCCC | 32.60 | 26074081 | |
1488 | Phosphorylation | TPACSRRSLRKTPLK CCCCCCCHHCCCCCC | 31.26 | 29496963 | |
1491 | Ubiquitination | CSRRSLRKTPLKTAN CCCCHHCCCCCCCCC | 60.84 | 24816145 | |
1492 | Phosphorylation | SRRSLRKTPLKTAN- CCCHHCCCCCCCCC- | 27.67 | 29496963 | |
1496 | Phosphorylation | LRKTPLKTAN----- HCCCCCCCCC----- | 38.83 | 21712546 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CNDD3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CNDD3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1384, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1329; THR-1331;SER-1348; SER-1357 AND SER-1384, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1328; SER-1329; THR-1331AND SER-1384, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1329 AND THR-1331, ANDMASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1357, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-507 AND SER-508, ANDMASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1393, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-531 AND SER-1384, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-972, AND MASSSPECTROMETRY. |